appears to have secured enough shares to acquire the Croatian generic-drug company
According to reports by
that cited information from Croatian regulators, Barr has received nearly 73% of Pliva's shares in a tender offer.
Barr needed a majority of Pliva's shares to complete the $2.5 billion offer as it bid against Iceland's
The tender offer is scheduled to expire at midnight Wednesday, and the official results will take about a week to count. The combination of Barr and Pliva will create the world's third-largest generic-drug company, behind
Teva Pharmaceutical Industries
and the Sandoz unit of